Disposable Versus Reusable DrApes and Gowns for Green OperatiNg Theatres
NCT ID: NCT06164444
Last Updated: 2025-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
26800 participants
INTERVENTIONAL
2024-11-12
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Chlorhexidine Wipe for Prevention of Multidrug-resistant Organisms in Intensive Care Unit Patients
NCT01989416
Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)
NCT05741866
Preoperative CHG Cloth on Healthy Subjects
NCT02291601
Bacterial Contamination on Obstetric Resident Surgical Scrubs
NCT02348866
Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth
NCT02224625
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim: This randomised controlled trial will assess whether reusable surgical drapes and gowns are non-inferior in reducing SSI compared to disposable drapes and gowns in patients undergoing surgery.
Design: Pragmatic 1:1 international multi-centre non-inferiority cluster randomised controlled trial, with an internal pilot. Clusters are individual hospitals.
Intervention: Reusable surgical drapes and gowns.
Comparator: Disposable (single-use) surgical drapes and gowns.
Sample size: The control group SSI event rate is estimated to be 12.5% based on previous literature. To determine whether reusable drapes and gowns are non-inferior to disposable drapes and gowns with a non-inferiority margin of 2.5% would require a total of 26,800 participants from 134 clusters, with an average of 200 participants per cluster, assuming 90% power, 2.5% one-sided alpha, intraclass correlation of 0.01 and 5% participant loss to follow up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
As this is a cluster randomised trial, outcome assessors are likely to know the hospital allocation and are therefore unlikely to be blinded. Assessors will receive formal training to undertake patient record review, in-person wound assessment, or telephone follow-up, as appropriate for their site. Assessors will collect detailed wound-related variables. The primary outcome of SSI will be determined by a computer-based algorithm based on the CDC criteria, using this data.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention: Reusable drapes and gowns
* Reusable drapes and gowns are made from cotton and polyester and are protective against fluid contamination and, to a certain extent, mechanical stress.
* Reusable drapes and gowns are usually autoclaved and laundered using pressurised steam. This ensures that bacteria and other microorganisms are killed, sterilising the fabric so it is suitable for re-use. In this pragmatic trial, a specific sterilisation protocol is not mandated, but details of the sterilisation processes in place at each hospital will be captured in the Hospital-level Questionnaire before site opening. We may report this in a paper ahead of the main trial publication.
Intervention: Reusable drapes and gowns
Reusable drapes and gowns used during surgery.
Comparator: Disposable (single-use) drapes and gowns
* Single-use surgical gowns and drapes are generally made from non-woven plastic polymers that are protective against fluid contamination and, to a certain extent, mechanical stress.
* They are intended for use during a single operation and are then disposed of as biohazard waste for incineration.
* Typically, four drapes are needed for an abdominal operation (two larger and two smaller drapes), although more may be needed for some procedures.
* A range of disposable gowns are available. The choice of disposable gown will be at the hospital PI's discretion and will be captured in the Hospital-level Questionnaire.
Comparator: Disposable (single-use) drapes and gowns
Disposable drapes and gowns used during surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention: Reusable drapes and gowns
Reusable drapes and gowns used during surgery.
Comparator: Disposable (single-use) drapes and gowns
Disposable drapes and gowns used during surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with a clean-contaminated, contaminated, or dirty surgical wound. Definitions of contamination are given in Table 2.
* Patients undergoing emergency (surgery on an unplanned admission) or elective (surgery on a planned admission) surgery.
* Any operative indication (including caesarean section).
* Patients aged 10 or over.
Exclusion Criteria
* Patients undergoing procedures with a clean surgical wound only.
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Christian Medical College, Vellore, India
OTHER
Kigali University Teaching Hospital
OTHER
Lagos State University
OTHER
Hospital Español de Mexico
OTHER
Christian Medical College and Hospital, Ludhiana, India
OTHER
Centre National Hospitalier Universitaire Hubert Koutoukou MAGA
UNKNOWN
University for Development Studies, Tamale, Ghana
OTHER
Chris Hani Baragwanath Academic Hospital
OTHER
University of Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aneel Bhangu
Role: PRINCIPAL_INVESTIGATOR
University of Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CMNO
Guadalajara, , Mexico
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Laura Martinez
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RG_22-181 - Q1085
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.